Nickel(II) thiohydrazide and thiodiamine complexes: synthesis, characterization, antibacterial, antifungal and thermal studies

Nickel(II) complexes of type [Ni(L)(2)Cl(2)] and [Ni(L)(2)(OCOCH(3))(2)], where L=N,N-diphenyl-N-thiohydrazide (L(1)) and (N,N-diphenyl-N-thio)-1,3-propanediamine (L(2)), have been synthesized. The thiodiamines coordinate as a bidentate N-S ligand. The synthesized nickel(II) complexes of the thiodiamines were characterized by elemental analysis, IR, mass, electronic and (1)H NMR spectroscopic and TG/DTA studies. Various kinetic and thermodynamic parameters like order of reaction (n), activation energy (E(a)), apparent activation entropy (S(#)) and heat of reaction (DeltaH) have also been carried out for one complex. These complexes were also screened for in vitro antifungal and in vitro antibacterial activities and significant activity have been found.     

Platinum(IV) and palladium(II) thiosemicarbazide and thiodiamine complexes: A spectral and antibacterial study

Platinum(IV) and palladium(II) complexes [Pt(L)₂Cl₂] and [Pd(L)Cl₂], [where, L?=?1,1-diphenyl-2-thiosemicarbazide (L¹) and (1,1-diphenyl-2-thio)-1,3-propanediamine (L²) have been synthesized. The thiosemicarbazides and thiodiamines exist as the thione-thiol tautomer and coordinate as a bidentate N-S ligand. The ligands are monobasic bidentate. The complexes have been characterized by elemental analysis, IR, mass, electronic and 1H NMR spectroscopic studies. In vitro antibacterial studies have also been carried out for some complexes.     

Synthesis,characterization, antimicrobial and diuretic study of Mg(II), Mn(II), Fe(II) and VO(II) complexes of chemotherapeutic importance

The synthesis, characterization and diuretic activity of four new biologically active complexes of Mg(II) and VO(II) with bidentate Schiff base ligand acetazolamide–salicylaldimine (L) obtained from the inserted condensation of 5-acetamido-1,3,4-thiadiazole-2-sulphonamide (acetazolamide) with salicylaldehyde in a 1:1 molar ratio have been reported. Using this bidentate ligand complexes of Mg(II), Mn(II), Fe(II) and VO(II) with general formula ML₂ have been synthesized. The synthesized complexes were characterized by several techniques using elemental analysis, FT-IR, electronic spectra, TGA, mass, particle size analysis and molar conductance measurements. The elemental analysis data suggest the stoichiometry to be 1:2 [M:L]. The molar conductance measurements suggest non-electrolytic nature of the complexes. Infrared spectral data agreed with the coordination to the central metal ion through deprotonated phenolic oxygen and azomethine nitrogen atoms. On the basis of spectral studies, octahedral geometry is suggested for Mg(II), Mn(II), Fe(II) and square pyramidal geometry is suggested for VO(II) complexes. The pure drug, synthesized ligand and metal(II) complexes were screened for their antimicrobial activities against Eschericia coli, Bacillus subtilis, Aspergillus niger and Aspergillus flavous. The results show that the metal complexes were more active than the ligand and pure drug against these microbial species as expected. The ligand and its Mg(II) complexes was screened for their diuretic activity also.     

Novel oxorhenium and oxotechnetium complexes from an aminothiol[NS]/thiol[S] mixed-ligand system

The simultaneous action of a bidentate aminothiol ligand, LnH, (n = 1: (CH3CH2)2NCH2CH2SH and n = 2: C5H10NCH2CH2SH) and a monodentate thiol ligand, LH (LH: p-methoxythiophenol) on a suitable MO (M = Re, 99gTc) precursor results in the formation of complexes of the general formula [MO(Ln)(L)3] (1, 2 for Re and 5. 6 for 99gTc). In solution these complexes gradually transform to [MO(Ln)(L)2] complexes (3, 4 for Re and 7, 8 for 99gTc). The transformation is much faster for oxotechnetium than for oxorhenium complexes. Complexes 1-4, 7, and 8 have been isolated and fully characterized by elemental analysis and spectroscopic methods. Detailed NMR assignments were made for complexes 3, 4, 7, and 8. X-ray studies have demonstrated that the coordination geometry around rhenium in complex 1 is square pyramidal (tau = 0.06), with four sulfur atoms (one from the L1H ligand and three from three molecules of p-methoxythiophenol) in the basal plane and the oxo group in the apical position. The L1H ligand acts as a monodentate ligand with the nitrogen atom being protonated and hydrogen bonded to the oxo group. The four thiols are deprotonated during complexation resulting in a complex with an overall charge of zero. The coordination geometry around rhenium in complex 4 is trigonally distorted square pyramidal (tau = 0.41), while in the oxotechnetium complex 7 it is square pyramidal (tau = 0.16). In both complexes LnH acts as a bidentate ligand. The NS donor atom set of the bidentate ligand and the two sulfur atoms of the two monodentate thiols define the basal plane, while the oxygen atom occupies the apical position. At the technetium tracer level (99mTc), both types of complexes, [99mTcO(Ln)(L)3] and [99mTcO(Ln)(L)2], are formed as indicated by HPLC. At high ligand concentrations the major complex is [99mTcO(Ln)(L)3], while at low concentrations the predominant complex is [99mTcO(Ln)(L)2]. The complexes [99mTcO(Ln)(L)3] transform to the stable complexes [99mTcO(Ln)(L)2]. This transformation is much faster in the absence of ligands. The complexes [99mTcO(Ln)(L)2] are stable, neutral, and also the predominant product of the reaction when low concentrations of ligands are used, a fact that is very important from the radiopharmaceutical point of view.     

New ruthenium(II) complexes with enantiomerically pure bis- and tris(pinene)-fused tridentate ligands. Synthesis, characterization and stereoisomeric analysis

A new set of Ru-Cl complexes containing either the pinene[5,6]bpea ligand (L1) or the C3 symmetric pinene[4,5]tpmOMe (L2) tridentate ligand in combination with the bidentate (B) 2,2'-bipyridine (bpy) or 1,2-diphenylphosphinoethane (dppe) with general formula [RuCl(L1 or L2)(B)](+) have been prepared and thoroughly characterized. In the solid state, X-ray diffraction analysis techniques have been used. In solution, cyclic voltammetry (CV) and 1D and 2D NMR spectroscopy have been employed. DFT calculations have been also performed on these complexes and their achiral analogues previously reported in our group, to interpret and complement experimental results. Whereas isomerically pure complexes ([Ru(II)Cl(L2)(bpy)](BF4), 5 and [Ru(II)Cl(L2)(dppe)](BF4), 6) are obtained when starting from the highly symmetric [Ru(III)Cl3(L2)], 2, isomeric mixtures of cis, fac-[Ru(II)Cl(L1)(bpy)](BF4) (3b/3b'), trans,fac- (3a) and up/down,mer- (3c, 3d) isomers are formed when bpy is added to the less symmetric [Ru(III)Cl3(L1)], 1, in contrast to the case of the bulky dppe ligand that, upon coordination to 1, leads to the trans,fac-[Ru(II)Cl(L1)(dppe)](BF4) (4a) complex as a sole isomer due to steric factors.     

Versatile coordinative abilities of a new hybrid pteridine-thiosemicarbazone ligand: crystal structure, spectroscopic characterization, and luminescent properties

The synthesis and characterization of the first thiosemicarbazone-lumazine (TSCLMH=the thiosemicarbazone of 6-acetyl-1,3,7-trimethyllumazine) hybrid ligand is reported. The influence of the conformation of this compound on its energy and the atomic contribution to the molecular orbitals have been theoretically investigated. Ni(II), Cu(I), Zn(II), and Cd(II) complexes of this ligand have been synthesized and characterized by elemental analysis, thermogravimetric studies, IR, 1H, 13C, and 15N NMR, and UV-vis-NIR spectroscopy, magnetic measurements, and X-ray crystallography. Four types of coordination modes for the ligand may be predicted: (a) double bidentate; (b) tetradentate; (c) tridentate; (d) bidentate. Structures of representative complexes of types a, b, and d have been determined by X-ray crystallography. In the [Cu(TSCLMH)]2(ClO4)2 complex, TSCLMH acts as a doubly bidentate bridging ligand forming a dimer with a Cu...Cu distance of 2.876 A. The geometry around the metal ion is trigonally distorted tetrahedral with a relatively long (four-atom) bridge between the metal centers instead of the shorter, mainly single atom, bridges present in other thiosemicarbazone derivatives complexes. In the [Cd(NO3)2(TSCLMH)(EtOH)] complex, the metal ion displays eight-coordinated geometry with the TSCLMH ligand acting in a tetradentate planar fashion and two nitrate anions, one monodentate and the other bidentate. The coordination polyhedron in [Cd(TSCLM)2(H2O)].MeOH.2H2O is a square pyramid with two monoanionic ligands acting as bidentate NS donors and a water molecule completing the coordination sphere. Fluorescence spectroscopic properties of TSCLMH have been studied as well as the changes in position and intensity of fluorescence bands caused by the complexation with different metal ions (Ni2+, Cu+, Zn2+, Cd2+).     

Palladium(II) thiohydrazone complexes: synthesis,spectral characterization and antifungal study

Palladium(II) complexes of type [Pd(L)Cl₂] [where, L?=?benzaldehyde-1,1-diphenyl-2-thiohydrazone (L¹), salicylaldehyde-1,1-diphenyl-2-thiohydrazone (L²), acetaphenone-1,1-diphenyl-2-thiohydrazone (L³) and cyclohexanone-1,1-diphenyl-2-thiohydrazone (L⁴)] have been synthesized. The thiohydrazones can exist as thione-thiol tautomers and coordinate as a bidentate N–S ligand. The ligands are found to be monobasic bidentate. The complexes have been characterized by elemental analysis, IR, mass, electronic, ¹H NMR spectroscopic studies. In vitro antifungal studies against fungi Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger for some complexes have also been carried out.     

Syntheses, structures, and photoluminescence properties of metal(II) halide complexes with pyridine-containing flexible tripodal ligands

Seven coordination compounds, [Zn(L3)Cl2] . MeOH . H2O (1), [Mn(L3)2Cl2] . 0.5EtOH . 0.5H2O (2), [Cu3(L2)2Cl6] . 2DMF (3), [Cu3(L2)2Br6] . 4MeOH (4), [Hg2(L4)Cl4] (5), [Hg2(L4)Br4] (6), and [Hg3(L4)2I6] . H2O (7), were synthesized by the reactions of ligands 1,3,5-tris(3-pyridylmethoxyl)benzene (L3), 1,3,5-tris(2-pyridylmethoxyl)benzene (L2), and 1,3,5-tris(4-pyridylmethoxyl)benzene (L4) with the corresponding metal halides. All the structures were established by single-crystal X-ray diffraction analysis. In complexes 1 and 2, L3 acts as a bidentate ligand using two of three pyridyl arms to link two metal atoms to result in two different 1D chain structures. In complexes 3 and 4, each L2 serves as tridentate ligand and connects three Cu(II) atoms to form a 2D network structure. Complexes 5 and 6 have the same framework structure, and L4 acts as a three-connecting ligand to connect Hg(II) atoms to generate a 3D 4-fold interpenetrated framework, while the structure of complex 7 is an infinite 1D chain. The results indicate that the flexible ligands can adopt different conformations and thus can form complexes with varied structures. In addition, the coordination geometry of the metal atom and the species of the halide were found to have great impact on the structure of the complexes. The photoluminescence properties of the complexes were investigated, and the Zn(II), Mn(II) and Hg(II) complexes showed blue emissions in solid state at room temperature.     

Synthesis, characterization, and reactivity of mononuclear O,N-chelated vanadium(IV) and -(III) complexes of methyl 2-Aminocyclopent-1-ene-1-dithiocarboxylate based ligand: reporting an example of conformational isomerism in the solid state

Vanadium(IV) and -(III) complexes of a tetradentate N(2)OS Schiff base ligand H(2)L [derived from methyl 2-((beta-aminoethyl)amino)cyclopent-1-ene-1-dithiocarboxylate and salicylaldehyde] are reported. In all the complexes, the ligand acts in a bidentate (N,O) fashion leaving a part containing the N,S donor set uncoordinated. The oxovanadium(IV) complex [VO(HL)(2)] (1) is obtained by the reaction between [VO(acac)(2)] and H(2)L. In the solid state, compound 1 has two conformational isomers 1a and 1b; both have been characterized by X-ray crystallography. Compound 1a has the syn conformation that enforces the donor atoms around the metal center to adopt a distorted tbp structure (tau = 0.55). Isomer 1b on the other hand has an anti conformation with almost a regular square pyramidal geometry (tau = 0.06) around vanadium. In solution, however, 1 prefers to be in the square pyramidal form. A second variety of vanadyl complex [VO(L(cyclic))(2)](I(3))(2) (2) with a new bidentate O,N donor ligand involving isothiazolium moiety has been obtained by a ligand-based oxidation of the precursor complex 1 with iodine. Preliminary X-ray and FAB mass spectroscopic data of 2 have supported the formation of a heterocyclic moiety by a ring closure reaction involving a N-S bond. Vanadium(III) complex [V(acac)(HL)(2)] (3) has been obtained through partial ligand displacement of [V(acac)(3)] with H(2)L. Compound 3 has almost a regular octahedral structure completed by two bidentate HL ligands along with an acetylacetonate molecule. Electronic spectra, magnetism, EPR, and redox properties of these compounds are reported.     

Synthesis,structure and characterization of binuclear copper(I) complexes

Binuclear copper(I) complexes [Cu(dppm)(NO3)]2 (1), dppm=Ph2PCH2PPh2, [Cu(dppm)(2,9-Me2Phen)]2(NO3)2 (2), [Cu(dppm)(I)]2 (3) and [Cu(dppm)(py)]2(NO3)2 (4), (py=pyridine) have been synthesized by ligand reduction of cupric nitrate with dppm in EtOH and characterized by elemental analyses, molecular weight determination, t.g.a., 31P-n.m.r spectra; their electronic conductivities and c.v. waves have also been measured. The results show that dppm coordinates as a bridging bidentate ligand to the CuI atoms, and that NO3 behaves as a monodentate ligand or free ion in the newly prepared complexes.     

Synthesis, characterization and thermal studies on metal complexes of new azo compounds derived from sulfa drugs

Four new azo ligands, L1 and HL2-4, of sulfa drugs have been prepared and characterized. [MX(2)(L1)(H(2)O)(m)].nH(2)O; [(MX(2))(2)(HL2 or HL3)(H(2)O)(m)].nH(2)O and [M(2)X(3)(L4)(H(2)O)].nH(2)O; M=Co(II), Ni(II) and Cu(II) (X=Cl) and Zn(II) (X=AcO); m=0-4 and n=0-3, complexes were prepared. Elemental and thermal analyses (TGA and DTA), IR, solid reflectance spectra, magnetic moment and molar conductance measurements have accomplished characterization of the complexes. The IR data reveal that HL1 and HL2-3 ligands behave as a bidentate neutral ligands while HL4 ligand behaves as a bidentate monoionic ligand. They coordinated to the metal ions via the carbonyl O, enolic sulfonamide S(O)OH, pyrazole or thiazole N and azo N groups. The molar conductance data reveal that the chelates are non-electrolytes. From the solid reflectance spectra and magnetic moment data, the complexes were found to have octahedral, tetrahedral and square planar geometrical structures. The thermal behaviour of these chelates shows that the water molecules (hydrated and coordinated) and the anions are removed in a successive two steps followed immediately by decomposition of the ligand in the subsequent steps. The activation thermodynamic parameters, such as, E*, DeltaH*, DeltaS* and DeltaG* are calculated from the TG curves applying Coats-Redfern method.     

Preparation, spectroscopy, EXAFS, electrochemistry and pharmacology of new ruthenium(II) carbonyl complexes containing ferrocenylthiosemicarbazone and triphenylphosphine/arsine

A new series of new hetero-bimetallic complexes containing iron and ruthenium of the general formula [RuCl(CO)(B)(EPh3)(L)] (where E=P or As; B=PPh3, AsPh3, py or pip; L=ferrocene derived monobasic bidentate thiosemicarbazone ligand) have been synthesized by the reaction between ferrocene-derived thiosemicarbazones and ruthenium(II) complexes of the type [RuHCl(CO)(B)(EPh3)2] (where E=P or As; B=PPh3, AsPh3, py or pip). The new complexes have been characterized by elemental analyses, IR, electronic, NMR (1H, 13C and 31P), EXAFS (extended X-ray absorption fine structure spectroscopy) and cyclic voltammetric techniques. Antibacterial activity of the new complexes has been screened against Escherichia coli, Vibrio cholerae, and Pseudomonas aeruginosa species.     

Synthesis, spectral characterization, thermal and photoluminescence properties of Zn(II) and Cd(II)-azido/thiocyanato complexes with thiazolylazo dye and 1,2-bis(diphenylphoshino)ethane

A series of complexes of the type [M(L)(dppe)X2]; where M=Zn(II) or Cd(II); L=4-(2'-thiazolylazo)chlorobenzene (L1), 4-(2'-thiazolylazo)bromobenzene (L2) and 4-(2'-thiazolylazo) iodobenzene (L3); dppe=1,2-bis(diphenylphosphino)ethane; X=N3- or NCS- have been prepared and characterized on the basis of their microanalysis, molar conductance, thermal, IR, UV-vis and 1H NMR spectral studies. IR spectra show that the ligand L is coordinated to the metal atom in bidentate manner via azo nitrogen and thiazole nitrogen. An octahedral structure is proposed for all the complexes. The thermal behavior of the complexes revealed that the thiocyanato complexes are thermally more stable than the azido complexes. All the complexes exhibit blue-green emission with high quantum yield as the result of the fluorescence from the intraligand emission excited state.     

Synthesis and spectroscopic studies of copper(II) and nickel(II) complexes containing hydrazonic ligands and heterocyclic coligand

Two types of copper(II) and nickel(II) complexes derived from benzophenone anthranoylhydrazone (L1), 2-acetonaftanone anthranoylhydrazone (L2), 4-phenylacetonaftonone anthranoylhydrazone (L3), benzophenone salicyoylhydrazone (L4), 2-acetonaftanon salicyoylhydrazone (L5), 4-phenylacetonaftanon salicyoylhydrazone (L6) and bidentate heterocyclic base [1,10-phenanthroline (phen)] with general stoichiometry [ML2] and [ML(phen)]Cl have been synthesized and characterized by elemental analysis, infrared spectra, UV-vis electronic absorption spectra and magnetic susceptibility measurements. The effect of varying pH and solvent on the absorption behavior of both ligands and complexes have been investigated. According to the IR spectra, the ligands act as monobasic bidentate and coordination takes place in the enol tautomeric form.     

A new family of mono- and dicarboxylic ruthenium complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): synthesis, solution behavior, and X-ray molecular structure of trans-[Ru(DIP)2(MeOH)2][OTf]2

A new family of ruthenium complexes of general formula [Ru(DIP)2(L2)]2+, where DIP = 4,7-diphenyl-1,10-phenanthroline, a bidentate ligand with an extended aromatic system, was prepared and fully characterized. When L is a monodentate ligand, the following complexes were obtained: L = CF3SO3(-1) (2), CH3CN (3), and MeOH (4). When L2 is a bidentate ligand, the compounds [Ru(DIP)2(Hcmbpy)][Cl]2 (5) and [Ru(DIP)2(H2dcbpy)][Cl]2 (6) were prepared (Hcmbpy = 4-carboxy-4'-methyl-2,2-bipyridine, H2dcbpy = 4,4'-dicarboxy-2,2'-bipyridine). Complex [Ru(DIP)2(MeOH)2][OTf]2 (4) displayed a trans configuration of the DIP ligands, which is rare for octahedral complexes featuring DIP bidentate ligands. DFT calculations carried out on 4 showed that the cis isomer is more stable by 12.2 kcal/mol relative to the trans species. The solution behaviors of monocarboxylic complex [Ru(DIP)2(Hcmbpy)][Cl]2 (5) and dicarboxylic complex [Ru(DIP)2(H2dcbpy)][Cl]2 (6) were investigated by 1H NMR spectroscopy. VT-NMR, concentration dependence, and reaction with NaOD allowed us to suggest that aggregation of the cationic species in solution, especially for 6, originates mainly from hydrogen bonding interactions.     

Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity

Areneruthenium(II) molecular complexes of the formula [Ru(arene)(Q)Cl], containing diverse 4-acyl-5-pyrazolonate ligands Q with arene = cymene or benzene, have been synthesized by the interaction of HQ and [Ru(arene)Cl(micro-Cl)]2 dimers in methanol in the presence of sodium methoxide. The dinuclear compound [{Ru(cymene)Cl}2Q4Q] (H2Q4Q = bis(4-(1-phenyl-3-methyl-5-pyrazolone)dioxohexane), existing in the RRuSRu (meso form), has been prepared similarly. [Ru(cymene)(Q)Cl] reacts with sodium azide in acetone, affording [Ru(cymene)(Q)N3] derivatives, where Cl- has been replaced by N3-. The reactivity of [Ru(cymene)(Q)Cl] has also been explored toward monodentate donor ligands L (L = triphenylphosphine, 1-methylimidazole, or 1-methyl-2-mercaptoimidazole) and exo-bidentate ditopic donor ligands L-L (L-L = 4,4'-bipyridine or bis(diphenylphosphino)propane) in the presence of silver salts AgX (X = SO3CF3 or ClO4), new ionic mononuclear complexes of the formula [Ru(cymene)(Q)L]X, and ionic dinuclear complexes of the formula [{Ru(cymene)(Q)}2L-L]X2 being obtained. The solid-state structures of a number of complexes were confirmed by X-ray crystallographic studies. Their redox properties have been investigated by cyclic voltammetry and controlled potential electrolysis, which, on the basis of their measured RuII/III reversible oxidation potentials, have allowed the ordering of the bidentate acylpyrazolonate ligands according to their electron-donor character and are indicative of a small dependence of the HOMO energy upon the change of the monodentate ligand. This is accounted for by DFT calculations, which show a relevant contribution of acylpyrazolonate ligand orbitals to the HOMOs, whereas that from the monodentate ligand is minor.     

Synthesis,structural characterization,and anti-ulcerogenic activity of schiff base ligands derived from tryptamine and 5-chloro, 5-nitro, 3,5-ditertiarybutyl salicylaldehyde and their nickel(II), copper(II), and zinc(II) complexes

Ni(II), Cu(II), and Zn(II) complexes with bidentate Schiff bases derived from the condensation reaction of 5-chlorosalicylaldehyde, 5-nitrosalicylaldehyde, and 3,5 ditertiarybutyl-2-hydroxy benzaldehyde with tryptamine, have been reported. The ligands and complexes were characterized by elemental analysis, IR, ¹H NMR and UV–Vis spectroscopy as well as single crystal X-ray structure analysis whenever possible. The complexes were found to have the general formula [M(L)₂]. Spectral studies reveal that these Schiff bases were acting as bidentate ligands and co-ordinating to the metal center through deprotonated phenolate oxygen and azomethine nitrogen atoms. The Zn(II) complexes establish a tetrahedral geometry in a 1:2 metal to ligand stoichiometry, whereas a square planar geometry was proposed for the nickel and copper complexes, slightly distorted in the case of the latter.The antiulcer activity of 5-chlorosalicylaldehyde derivative and its nickel and copper complexes were evaluated in ethanol-induced gastric mucosal injury in rats. This Schiff base and its complexes promote ulcer protection as ascertained by the comparative decrease in ulcer areas, and inhibition of edema and leucocyte infiltration of the submucosal layer.     

Anionic Fischer-type carbene complexes as bidentate (N,O) ligands

New polynuclear complexes, (L1)3M2 [M2 = Cr(III) (4a,4b), Fe(III) (5), Co(III) (8)], (L1)2M2(L2)2 [M2 = Co(II) (7), Ni(II) (9)], (L1)2M2(O)L2 [M2 = V(IV) (6)] and L1M2Cp2 [M2 = Ti(III) (10)] with L1 = (CO)5M1=C[C=NC(CH3)=CHS](O-)(M1 = Cr or W) and L2 = 4-methylthiazole or THF, are described. The molecular structures of these complexes determined by X-ray diffraction show that the Fischer-type carbene complexes act as bidentate ligands towards the second metal centre, coordinating through C(carbene)-attached O-atoms and imine N-atoms of the thiazolyl groups to form five-membered chelates with the oxygen atoms in the mer configuration. Isostructural complexes have similar characteristic band patterns in their far-IR spectra. Cyclic voltammetry of selected complexes reveals the oxidation of the carbene complex ligand between 1.01 and 1.29 V. Oxidation of the central metal (M2) takes place at 0.56 and 0.86 V for 7 and 9, respectively. Three stepwise reductions of Cr(III) to Cr(0) occur for 4a and 4b in the region -0.51 to -1.58 V. These new ligand types and other variants thereof should find application in ligand design with the first metal -- and other ligands attached thereto -- in the carbene complex ligand, playing an important role.     

Structural and thermal characterization of ternary complexes of piroxicam and alanine with transition metals: uranyl binary and ternary complexes of piroxicam. Spectroscopic characterization and properties of metal complexes

Ternary Fe(III), Co(II), Ni(II), Cu(II), Zn(II) and UO2(II) complexes with piroxicam (Pir) drug (H2L1) and dl-alanine (Ala) (HL2) and also the binary UO2(II) complex with Pir were studied. The structures of the complexes were elucidated using elemental, IR, molar conductance, magnetic moment, diffused reflectance and thermal analyses. The UO2(II) binary complex was isolated in 1:2 ratio with the formula [UO2(H2L)2](NO3)2. The ternary complexes were isolated in 1:1:1 (M:H2L1:L2) ratios. The solid complexes were isolated in the general formulae [M(H2L)(L2)(Cl)n(H2O)m].yH2O (M=Fe(III) (n=2, m=0, y=1), Co(II) (n=1, m=1, y=2) and Ni(II) (n=1, m=1, y=0)); [M(H2L)(L2)](X)z.yH2O (M=Cu(II) (X=AcO, z=1, y=0), Zn(II) (X=AcO, z=1, y=3) and UO2(II) (X=NO3, z=1, y=2)). Pir behaves as a neutral bidentate ligand coordinated to the metal ions via the pyridine-N and carbonyl-O groups, while Ala behaves as a uninegatively bidentate ligand coordinated to the metal ions via the deprotonated carboxylate-O and amino-N. The magnetic and reflectance spectral data show that the complexes have octahedral geometry except Cu(II) and Zn(II) complexes have tetrahedral structures. The thermal decomposition of the complexes was discussed in relation to structure, and the thermodynamic parameters of the decomposition stages were evaluated.